Sai Life Sciences (BOM:544306) Total Operating Expense: ₹4,742 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544306 Sai Life Sciences Ltd BOM:544306
18 GF Score
Price ₹1,273.25
! 5 Warning Signs
View Full Analysis

What is Sai Life Sciences Total Operating Expense?

Sai Life Sciences BOM:544306 -1.60% 18 Total Operating Expense is ₹4,742 Mil as of Mar. 2026. GuruFocus rates BOM:544306 with a GF Score™ of 18/100. The stock has 5 warning signs investors should review.

Sai Life Sciences's Total Operating Expense for the three months ended in Mar. 2026 was ₹1,225 Mil. Sai Life Sciences's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4,742 Mil.

Sai Life Sciences Total Operating Expense Related Terms

Sai Life Sciences Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Sai Life Sciences's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sai Life Sciences Total Operating Expense Chart

Sai Life Sciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
2,315.01 2,413.56 3,066.51 4,126.00 4,742.41

Sai Life Sciences Quarterly Data
Mar22 Mar23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,406.05 1,114.80 1,284.77 1,117.47 1,225.37
BOM:544306
18GF Score
Sai Life Sciences Ltd BOM:544306
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sai Life Sciences Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4,742 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹4,742 Mil mean?
Sai Life Sciences (BOM:544306) has a Total Operating Expense of ₹4,742 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Sai Life Sciences and its competitors.
Is Sai Life Sciences' Total Operating Expense too high?
Sai Life Sciences' current Total Operating Expense is ₹4,742 Mil. Overall, Sai Life Sciences has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sai Life Sciences' Total Operating Expense compare to TMO and DHR?
Sai Life Sciences' Total Operating Expense of ₹4,742 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Diagnostics & Research company?
A good Total Operating Expense depends on the Medical Diagnostics & Research industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Sai Life Sciences and its competitors. Sai Life Sciences's current Total Operating Expense is ₹4,742 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Life Sciences stock overvalued right now?
Sai Life Sciences (BOM:544306) has a current Total Operating Expense of ₹4,742 Mil. The current Total Operating Expense is ₹4,742 Mil. Sai Life Sciences' overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Sai Life Sciences (BOM:544306), the current Total Operating Expense is ₹4,742 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sai Life Sciences Business Description

Other Exchanges SAILIFE:India
Address Gachibowli Miyapur Road, L4- 01 & 02, SLN Terminus Survey, Survey no. 133, Gachibowli, Hyderabad, TG, IND, 500032
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
18GF Score

Get the complete analysis for BOM:544306

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,273.25
Price